{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:10:14Z","timestamp":1757455814340,"version":"3.40.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1007\/s42770-019-00067-5","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:29:28Z","timestamp":1552681768000},"page":"347-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Perennial Use of the Green Fluorescent Protein Marker in a Live Vaccinia Virus Ankara Recombinant Platform Shows No Acute Adverse Effects in Mice"],"prefix":"10.1007","volume":"50","author":[{"given":"D. S. O.","family":"Daian e Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M. G.","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Rachid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. F.","family":"Barbosa-Stancioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. G.","family":"Da Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"67_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1377\/hlthaff.2015.1088","volume":"35","author":"J Luyten","year":"2016","unstructured":"Luyten J, Beutels P (2016) The social value of vaccination programs: beyond cost-effectiveness. Health Aff (Millwood) 35:212\u2013218","journal-title":"Health Aff (Millwood)"},{"key":"67_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nm1218","volume":"11","author":"BC Buckland","year":"2005","unstructured":"Buckland BC (2005) The process development challenge for a new vaccine. Nat Med 11:16\u201319","journal-title":"Nat Med"},{"key":"67_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJMp1506820","volume":"373","author":"SA Plotkin","year":"2015","unstructured":"Plotkin SA, Mahmoud AAF, Farrar J (2015) Establishing a global vaccine-development fund. N Engl J Med 373:297\u2013300","journal-title":"N Engl J Med"},{"key":"67_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2217\/fvl-2017-0086","volume":"12","author":"LM Andrade","year":"2017","unstructured":"Andrade LM, Cox L, Versiani AF, da Fonseca FG (2017) A growing world of small things: a brief review on the nanostructured vaccines. Futur Virol 12:767\u2013779","journal-title":"Futur Virol"},{"key":"67_CR5","first-page":"2637","volume-title":"Fields Virology 2","author":"B Moss","year":"2007","unstructured":"Moss B (2007) Poxviridae: the viruses and their replication. In: Fields Virology 2, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2637\u20132267","edition":"5"},{"key":"67_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","volume":"239","author":"B Moss","year":"2011","unstructured":"Moss B (2011) Smallpox vaccines: targets of protective immunity. Immunol Rev 239:8\u201326","journal-title":"Immunol Rev"},{"key":"67_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2217\/fvl.13.129","volume":"9","author":"BR Quinan","year":"2014","unstructured":"Quinan BR, Daian e Silva DSO, Coelho FM, Da Fonseca FG (2014) Modified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine. Futur Virol 9:173\u2013187","journal-title":"Futur Virol"},{"key":"67_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.copbio.2004.09.001","volume":"15","author":"I Drexler","year":"2004","unstructured":"Drexler I, Staib C, Sutter G (2004) Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? Curr Opin Biotechnol 15:506\u2013512","journal-title":"Curr Opin Biotechnol"},{"key":"67_CR9","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1016\/j.vaccine.2013.03.042","volume":"31","author":"B Moss","year":"2013","unstructured":"Moss B (2013) Reflections on the early development of poxvirus vectors. Vaccine. 31:4220\u20134222","journal-title":"Vaccine."},{"key":"67_CR10","doi-asserted-by":"publisher","first-page":"ftv097","DOI":"10.1093\/femspd\/ftv097","volume":"73","author":"M Zuverink","year":"2015","unstructured":"Zuverink M, Barbieri JT (2015) From GFP to \u03b2-lactamase: advancing intact cell imaging for toxins and effectors. Pathog Dis 73:ftv097","journal-title":"Pathog Dis"},{"key":"67_CR11","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1073\/pnas.0401939101","volume":"101","author":"H Bisht","year":"2004","unstructured":"Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B (2004) Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A 101:6641\u20136646","journal-title":"Proc Natl Acad Sci U S A"},{"key":"67_CR12","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/sj.bjp.0703756","volume":"131","author":"DG Souza","year":"2000","unstructured":"Souza DG, Cara DC, Cassali GD, Coutinho SF, Silveira MR, Andrade SP, Poole SP, Teixeira MM (2000) Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. Br J Pharmacol 131:1800\u20131808","journal-title":"Br J Pharmacol"},{"key":"67_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s00011-004-1299-4","volume":"53","author":"LS Barcelos","year":"2004","unstructured":"Barcelos LS, Talvani A, Teixeira AS, Cassali GD, Andrade SP, Teixeira MM (2004) Production and in vivo effects of chemokines CXCL1-3\/KC and CCL2\/JE in a model of inflammatory angiogenesis in mice. Inflamm Res 53:576\u2013584","journal-title":"Inflamm Res"},{"key":"67_CR14","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.1073\/pnas.92.25.11899","volume":"92","author":"H Ogawa","year":"1995","unstructured":"Ogawa H, Inouye S, Tsuji FI, Yasuda K, Umesono K (1995) Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc Natl Acad Sci U S A 92:11899\u201311903","journal-title":"Proc Natl Acad Sci U S A"},{"key":"67_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00705-003-0006-z","volume":"148","author":"JC Ramirez","year":"2003","unstructured":"Ramirez JC, Finke D, Esteban M, Kraehenbuhl JP, Acha-Orbea H (2003) Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration. Arch Virol 148:827\u2013839","journal-title":"Arch Virol"},{"key":"67_CR16","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1089\/ars.2009.2538","volume":"11","author":"BS van der Veen","year":"2009","unstructured":"van der Veen BS, de Winther MP, Heeringa P (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899\u20132937","journal-title":"Antioxid Redox Signal"},{"key":"67_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874315300902010001","volume":"2","author":"IW Bekheet","year":"2009","unstructured":"Bekheet IW, Madkour ME, Ghaffar NA, Nosseir MMF, Moussa MM, Ibraheim RA, Ateya ME (2009) The role of myeloperoxidase in hepatitis C virus infection and associated liver cirrhosis. Open Trop Med J 2:1\u20137","journal-title":"Open Trop Med J"},{"key":"67_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcrc.2010.09.001","volume":"26","author":"N Kothari","year":"2011","unstructured":"Kothari N, Keshari RS, Bogra J, Kohli M, Abbas H, Malik A, Dikshit M, Barthwal MK (2011) Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J Crit Care 26:435\u2013e1-435-e.7","journal-title":"J Crit Care"},{"key":"67_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00005-011-0156-8","volume":"60","author":"Z Prokopowicz","year":"2012","unstructured":"Prokopowicz Z, Marcinkiewicz J, Katz DR, Chain BM (2012) Neutrophil myeloperoxidase: soldier and statesman. Arch Immunol Ther Exp 60:43\u201354","journal-title":"Arch Immunol Ther Exp"},{"key":"67_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1189\/jlb.1204697","volume":"77","author":"SJ Klebanoff","year":"2005","unstructured":"Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598\u2013625","journal-title":"J Leukoc Biol"},{"key":"67_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bpg.2013.08.002","volume":"27","author":"L Edwards","year":"2013","unstructured":"Edwards L, Wanless IR (2013) Mechanisms of liver involvement in systemic disease. Best Pract Res Clin Gastroenterol 27:471\u2013483","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"67_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/CS20100427","volume":"121","author":"F Campos","year":"2011","unstructured":"Campos F, Rodr\u00edguez-Y\u00e1\u00f1ez M, Castellanos M, Arias S, P\u00e9rez-Mato M, Sobrino T, Blanco M, Serena J, Castillo J (2011) Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels. Clin Sci 121:11\u201317","journal-title":"Clin Sci"},{"key":"67_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","volume":"245","author":"J Ozer","year":"2008","unstructured":"Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology. 245:194\u2013205","journal-title":"Toxicology."},{"key":"67_CR24","doi-asserted-by":"publisher","first-page":"e01042","DOI":"10.1128\/JVI.01042-17","volume":"91","author":"PL Earl","year":"2017","unstructured":"Earl PL, Americo JL, Moss B (2017) Insufficient innate immunity contributes to the susceptibility of the castaneous mouse to orthopoxvirus infection. J Virol 91:e01042\u2013e01017","journal-title":"J Virol"},{"issue":"6","key":"67_CR25","doi-asserted-by":"publisher","first-page":"e0156637","DOI":"10.1371\/journal.pone.0156637","volume":"11","author":"SD Dowall","year":"2016","unstructured":"Dowall SD, Graham VA, Rayner E, Hunter L, Watson R, Taylor I et al (2016) Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses. PLoS One 11(6):e0156637","journal-title":"PLoS One"},{"key":"67_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biologicals.2018.05.004","volume":"54","author":"MC Langenmayer","year":"2018","unstructured":"Langenmayer MC, L\u00fclf-Averhoff AT, Adam-Neumair S, Fux R, Sutter G, Volz A (2018) Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S. Biologicals. 54:58\u201362","journal-title":"Biologicals."},{"key":"67_CR27","doi-asserted-by":"publisher","first-page":"10840","DOI":"10.1128\/JVI.01524-14","volume":"88","author":"LE Dom\u00ednguez","year":"2014","unstructured":"Dom\u00ednguez LE, Brandm\u00fcller C, Zorn J, Kirschning CJ, Sutter G, Lehmann MH et al (2014) Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara. J Virol 88:10840\u201310850","journal-title":"J Virol"},{"key":"67_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.4049\/jimmunol.1301410","volume":"194","author":"PJ Price","year":"2015","unstructured":"Price PJ, B\u00e1nki Z, Scheideler A, Stoiber H, Verschoor A, Sutter G et al (2015) Complement component C5 recruits neutrophils in the absence of C3 during respiratory infection with modified vaccinia virus Ankara. J Immunol 194:1164\u20131168","journal-title":"J Immunol"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-019-00067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-019-00067-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-019-00067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:35:48Z","timestamp":1744176948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-019-00067-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,1]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1007\/s42770-019-00067-5","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"type":"print","value":"1517-8382"},{"type":"electronic","value":"1678-4405"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures reported here are in accordance with the ethical principles of animal experimentation adopted by the Ethics Committee for Animal experiments from Universidade Federal de Minas Gerais (CETEA\/UFMG\u2014protocol 273\/2008).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}